JOSEPH M FECZKO
CIK 1319874 · Senior Vice President · last filed 2022-10-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.80M
Companies
3
Total Filings
73
Lifetime Open-Market Net
-$2.18M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 8
73 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-05-24 | CCXI | Exer (M) | +11,795 | $0 | EDGAR |
| 2015-06-18 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2015-05-26 | CCXI | Mixed | +27,027 | $0 | EDGAR |
| 2013-09-16 | CCXI | Buy (P) | +10,000 | $60.3K | EDGAR |
| 2013-06-21 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2013-05-28 | CCXI | Grant (A) | — | $0 | EDGAR |
| 2012-06-26 | CCXI | Grant (A) | — | $0 | EDGAR |
| 2012-06-22 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2012-04-27 | CCXI | Grant (A) | — | $0 | EDGAR |
| 2012-04-10 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Buy (P) | +20,000 | $32.4K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.